Location: BURLINGTON, VT
CIK: 0001618205 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $176M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS INC | 409,387 | $2.849M | 1.6% | $4.01 | 0.0% | COM | 75955J402 |
| OCUL | OCULAR THERAPEUTIX INC | 320,000 | $2.71M | 1.5% | $9.83 | 0.0% | COM | 67576A100 |
| CLDX | CELLDEX THERAPEUTICS INC | 70,095 | $2.223M | 1.3% | $25.41 | 0.0% | COM NEW | 15117B202 |
| CMPS | COMPASS PATHWAYS LTD | 375,000 | $2.074M | 1.2% | $5.53 | — | SPONSORED ADS | 20451W101 |
| ENGN | ENGENE HOLDINGS INC | 250,000 | $1.702M | 1.0% | $9.66 | 0.0% | COM | 29286M105 |
| ZBIO | ZENAS BIOPHARMA INC | 70,000 | $1.369M | 0.8% | $21.89 | 0.0% | COM | 98937L105 |
| BIIB | BIOGEN INC | 5,000 | $917K | 0.5% | $183.25 | 0.0% | COM | 09062X103 |
| LPCN | LIPOCINE INC | 111,786 | $893K | 0.5% | $9.20 | 0.0% | COM NEW | 53630X203 |
| IDYA | IDEAYA BIOSCIENCES INC | 16,860 | $562K | 0.3% | $33.87 | 0.0% | COM | 45166A102 |
| RCUS | ARCUS BIOSCIENCES INC | 25,889 | $559K | 0.3% | $21.27 | 0.0% | COM | 03969F109 |
| RGNX | REGENXBIO INC | 66,270 | $555K | 0.3% | $11.60 | 0.0% | COM | 75901B107 |
| — | KARYOPHARM THERAPEUTICS INC | 83,952 | $468K | 0.3% | $5.57 | — | COM | 48576U106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 127,025 | $455K | 0.3% | $3.61 | 0.0% | COM | 77313F106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 20,100 | $393K | 0.2% | $30.84 | 0.0% | COM | 92790C104 |
| GRCE | GRACE THERAPEUTICS INC | 50,000 | $232K | 0.1% | $3.72 | 0.0% | COM | 00439U104 |
| KYNB | KYNTRA BIO INC | 22,566 | $153K | 0.1% | $8.36 | 0.0% | COM NEW | 31572Q881 |
| QNRX | QUOIN PHARMACEUTICALS LTD | 20,000 | $132K | 0.1% | $6.60 | — | SPONSORED ADS | 74907L409 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTLA | INTELLIA THERAPEUTICS INC | 445,400 (+41.2%) | $5.71M (+101.4%) | 3.3% | $12.62 | -1.7% | COM | 45826J105 |
| BMY | BRISTOL-MYERS SQUIBB CO | 306,268 (+1.1%) | $18.58M (+13.7%) | 10.6% | $44.84 | +28.1% | COM | 110122108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 100,000 (+11.1%) | $4.82M (-23.0%) | 2.7% | $32.39 | — | SPONS ADR | 86366E106 |
| UTHR | UNITED THERAPEUTICS CORP | 4,500 (+50.0%) | $2.668M (+82.5%) | 1.5% | $222.21 | +116.2% | COM | 91307C102 |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 1,500,000 (+200.0%) | $1.98M (+111.8%) | 1.1% | $1.75 | +15.8% | COM | 69404D108 |
| QURE | UNIQURE NV | 100,697 (+227.1%) | $1.646M (+123.5%) | 0.9% | $20.16 | +16.9% | SHS | N90064101 |
| — | QUIDELORTHO CORP | 82,548 (+13.8%) | $1.356M (-34.5%) | 0.8% | $59.19 | — | COM | 74838J101 |
| NVCR | NOVOCURE LTD | 202,330 (+33.0%) | $2.205M (+12.1%) | 1.3% | $15.28 | -17.7% | ORD SHS | G6674U108 |
| PRTA | PROTHENA CORP PLC | 449,019 (+1.8%) | $4.364M (+3.6%) | 2.5% | $20.62 | -55.8% | SHS | G72800108 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 17,503 (+3.0%) | $40,957 (+78.5%) | 0.0% | $13.60 | -80.8% | COM | 98943L107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | 253,000 | $3.603M | 2.1% | $7.94 | +80.1% | — | 03152W109 |
| MASI | MASIMO CORP | 8,280 | $1.077M | 0.6% | $81.54 | +78.0% | — | 574795100 |
| TXG | 10X GENOMICS INC | 59,000 | $962K | 0.5% | $15.11 | +31.4% | — | 88025U109 |
| VTYX | VENTYX BIOSCIENCES INC | 100,827 | $910K | 0.5% | $8.08 | +67.4% | — | 92332V107 |
| ILMN | ILLUMINA INC | 6,000 | $787K | 0.4% | $117.40 | +15.4% | — | 452327109 |
| — | BIOHAVEN LTD | 59,365 | $670K | 0.4% | $11.29 | — | — | G11196105 |
| TMCI | TREACE MEDICAL CONCEPTS INC | 226,947 | $556K | 0.3% | $6.12 | -61.6% | — | 89455T109 |
| RAPT | RAPT THERAPEUTICS INC | 15,000 | $508K | 0.3% | $31.06 | +62.6% | — | 75382E208 |
| ATEC | ALPHATEC HOLDINGS INC | 18,058 | $380K | 0.2% | $8.72 | +82.9% | — | 02081G201 |
| LQDA | LIQUIDIA TECHNOLOGIES INC | 10,000 | $345K | 0.2% | $28.47 | +33.2% | — | 53635D202 |
| INBX | INHIBRX BIOSCIENCES INC | 3,698 | $292K | 0.2% | $14.64 | +430.8% | — | 45720N103 |
| ALMS | ALUMIS INC | 10,000 | $97,600 | 0.1% | $12.13 | +100.6% | — | 022307102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OLMA | OLEMA PHARMACEUTICALS INC | 219,000 (-18.6%) | $3.265M (-51.4%) | 1.9% | $9.40 | +170.9% | COM | 68062P106 |
| CSTL | CASTLE BIOSCIENCES INC | 12,900 (-84.0%) | $317K (-89.9%) | 0.2% | $23.48 | +56.6% | COM | 14843C105 |
| KLAC | KLA CORPORATION | 19,883 (-9.1%) | $29.28M (+10.1%) | 16.7% | $798.69 | +83.1% | COM NEW | 482480100 |
| PHR | PHREESIA INC | 14,300 (-87.1%) | $120K (-93.6%) | 0.1% | $21.44 | -33.5% | COM | 71944F106 |
| IMNM | IMMUNOME INC | 50,000 (-61.5%) | $1.093M (-60.8%) | 0.6% | $10.60 | +117.6% | COM | 45257U108 |
| STOK | STOKE THERAPEUTICS INC | 210,000 (-19.2%) | $6.838M (-17.1%) | 3.9% | $12.13 | +162.5% | COM | 86150R107 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 35,000 (-36.4%) | $3.689M (-23.2%) | 2.1% | $39.90 | +108.7% | COM | 74366E102 |
| HROW | HARROW HEALTH INC | 24,000 (-29.4%) | $846K (-49.2%) | 0.5% | $6.05 | +696.1% | COM | 415858109 |
| CMPX | COMPASS THERAPEUTICS INC | 1,465,867 (-8.0%) | $7.754M (-9.3%) | 4.4% | $3.82 | +57.2% | COM | 20454B104 |
| LRCX | LAM RESEARCH CORPORATION | 36,000 (-10.7%) | $7.692M (+11.4%) | 4.4% | $155.36 | +45.4% | COM NEW | 512807306 |
| TVTX | TRAVERE THERAPEUTICS INC | 29,200 (-32.1%) | $868K (-47.2%) | 0.5% | $13.34 | +132.6% | COM | 89422G107 |
| SLDB | SOLID BIOSCIENCES INC | 625,980 (-11.3%) | $4.507M (+13.2%) | 2.6% | $5.15 | +17.4% | COM NEW | 83422E204 |
| APGE | APOGEE THERAPEUTICS INC | 9,000 (-43.8%) | $758K (-37.3%) | 0.4% | $38.35 | +88.3% | COM | 03770N101 |
| CORT | CORCEPT THERAPEUTICS INC | 47,200 (-29.8%) | $1.903M (-18.6%) | 1.1% | $14.57 | +166.3% | COM | 218352102 |
| GOSS | GOSSAMER BIO INC | 18,176 (-86.8%) | $5,971 (-98.6%) | 0.0% | $5.35 | -57.9% | COM | 38341P102 |
| AXSM | AXSOME THERAPEUTICS INC | 6,000 (-1.0%) | $1.014M (-8.4%) | 0.6% | $94.39 | +91.0% | COM | 05464T104 |
| DCGO | DOCGO INC | 39,573 (-20.7%) | $24,895 (-43.2%) | 0.0% | $4.44 | -81.8% | COM | 256086109 |
| ELUT | ELUTIA INC | 165,094 (-37.2%) | $173K (-4.9%) | 0.1% | $5.84 | -84.0% | COM | 05479K106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BIODESIX INC | 286,804 | $4.159M | 2.4% | $5.56 | — | COM | 09075X108 |
| OVV | OVINTIV INC | 107,500 | $6.381M | 3.6% | $35.12 | +24.4% | COM | 69047Q102 |
| BCYC | BICYCLE THERAPEUTICS PLC | 463,599 | $2.151M | 1.2% | $7.30 | — | SPONSORED ADS | 088786108 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 195,000 | $2.166M | 1.2% | $11.94 | +14.7% | COM | 71722W107 |
| NKTR | NEKTAR THERAPEUTICS | 31,000 | $2.23M | 1.3% | $53.00 | -8.8% | COM | 640268306 |
| ACAD | ACADIA PHARMACEUTICALS INC | 171,000 | $3.806M | 2.2% | $27.98 | -9.9% | COM | 004225108 |
| VERA | VERA THERAPEUTICS INC | 44,000 | $1.77M | 1.0% | $35.52 | +26.6% | CL A | 92337R101 |
| ALKS | ALKERMES PLC | 50,000 | $1.768M | 1.0% | $21.00 | +54.0% | SHS | G01767105 |
| VSTM | VERASTEM INC | 150,000 | $795K | 0.5% | $8.91 | -27.3% | COM NEW | 92337C203 |
| EQT | EQT CORPORATION | 34,619 | $2.203M | 1.3% | $33.40 | +65.5% | COM | 26884L109 |
| XENE | XENON PHARMACEUTICALS INC | 21,000 | $1.221M | 0.7% | $34.29 | +22.4% | COM | 98420N105 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 27,190 | $3.582M | 2.0% | $73.35 | +83.1% | COM | 64125C109 |
| LUNG | PULMONX CORP | 250,221 | $323K | 0.2% | $1.88 | -7.8% | COM | 745848101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 57,000 | $1.147M | 0.7% | $15.61 | -0.8% | COM | 483497103 |
| APLS | APELLIS PHARMACEUTICALS INC | 14,000 | $563K | 0.3% | $39.43 | -42.5% | COM | 03753U106 |
| FHTX | FOGHORN THERAPEUTICS INC | 281,730 | $1.347M | 0.8% | $16.56 | -65.7% | COM | 344174107 |
| FCX | FREEPORT-MCMORAN CL-B | 18,040 | $1.06M | 0.6% | $37.70 | +62.1% | CL-B | 35671D857 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 62,000 | $1.299M | 0.7% | $37.12 | -37.1% | COM | 90400D108 |
| CGEM | CULLINAN THERAPEUTICS INC | 20,000 | $284K | 0.2% | $40.60 | -70.5% | COM | 230031106 |
| CYTK | CYTOKINETICS INC | 30,000 | $1.977M | 1.1% | $36.48 | +76.6% | COM | 23282W605 |
| CADL | CANDEL THERAPEUTICS INC | 60,000 | $294K | 0.2% | $5.91 | -2.9% | COM | 137404109 |
| HALO | HALOZYME THERAPEUTICS INC | 10,100 | $653K | 0.4% | $51.35 | +43.4% | COM | 40637H109 |
| BBIO | BRIDGEBIO PHARMA INC | 8,688 | $645K | 0.4% | $41.64 | +78.9% | COM | 10806X102 |
| PHVS | PHARVARIS N V | 29,847 | $843K | 0.5% | $23.14 | +15.6% | COM | N69605108 |
| — | OUTSET MEDICAL INC | 98,882 | $380K | 0.2% | $9.28 | — | COM | 690145107 |
| KBDC | KAYNE ANDERSON BDC INC | 20,000 | $274K | 0.2% | $14.18 | +0.6% | COM SHS | 48662X105 |
| VYGR | VOYAGER THERAPEUTICS INC | 74,918 | $289K | 0.2% | $4.67 | — | COM | 92915B106 |
| TRIN | TRINITY CAP INC | 20,000 | $294K | 0.2% | $14.09 | +11.8% | COM | 896442308 |